Clinical Trials Using Verteporfin
Clinical trials are research studies that involve people. The clinical trials on this list are studying Verteporfin. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
The purpose of this Phase II study is to evaluate the efficacy and safety of Continuous Low- Irradiance Photodynamic Therapy (CLIPT) when used with Verteporfin in the treatment of cutaneous metastases of breast cancer for which no curative or significantly palliative therapy exists, including chest wall therapy.
Location: 3 locations
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
This phase I / II trial studies the side effects and best dose of Verteporfin and to see how well it works in treating patients with high grade EGFR-mutated glioblastoma that has come back (recurrent). Verteporfin may increase body's sensitivity to light, which may help to kill cancer cells.
Location: Emory University Hospital / Winship Cancer Institute, Atlanta, Georgia
Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System
The rationale for the study is to obtain safety data as well as to establish dose parameters for the SpectraCure P18 System with IDOSE®, with verteporfin for injection (VFI) as photosensitizer for the treatment of recurrent prostate cancer.
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
This phase II trial studies how well ultrasound-guided verteporfin photodynamic therapy works for the treatment of patients with solid pancreatic tumors that cannot be removed by surgery (unresectable) or pancreatic cancer that has spread to other places in the body (advanced). Photodynamic therapy is a type of laser device that is guided by ultrasound imaging and used in combination with the drug verteporfin that may be less invasive and as effective as current treatment methods for patients with pancreatic cancer.
Location: Mayo Clinic in Rochester, Rochester, Minnesota